RB

Rinkuben Bhargav Patel

Active Director Designated Partner DIN 10889107
DIN 10889107 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rinkuben Bhargav Patel

Data last updated:

Rinkuben Bhargav Patel is a Designated Partner at Enormous Pharma Chem Llp (since 2024).

DIN 10889107
Primary Designation Designated Partner
First Appointment 27 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Dec 20242024Active

Board colleagues of Rinkuben Bhargav Patel

NameDINCompanyDesignation
Dipakkumar Ramashanker Kashyap10889109Enormous Pharma Chem LlpDesignated Partner
Girishbhai Ishvarbhai Mevada10889108Enormous Pharma Chem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Enormous Pharma Chem Llp
Premium access

Shareholding and investment profile for Rinkuben Bhargav Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rinkuben Bhargav Patel

Rinkuben Bhargav Patel currently holds 1 directorship: Enormous Pharma Chem Llp (Designated Partner, since 27 Dec 2024).

Rinkuben Bhargav Patel was first appointed on 27 Dec 2024 as Designated Partner at Enormous Pharma Chem Llp.

The current boards of Rinkuben Bhargav Patel's companies include Dipakkumar Ramashanker Kashyap (Enormous Pharma Chem Llp), Girishbhai Ishvarbhai Mevada (Enormous Pharma Chem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available